|
SUMO3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.760400E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.721600E-01 |
| Normal-vs-Stage2 |
1.685660E-02 |
| Normal-vs-Stage3 |
1.856020E-02 |
| Normal-vs-Stage4 |
2.858900E-03 |
| Stage1-vs-Stage2 |
5.227900E-02 |
| Stage1-vs-Stage3 |
3.918300E-02 |
| Stage1-vs-Stage4 |
7.898200E-03 |
| Stage2-vs-Stage3 |
7.144800E-01 |
| Stage2-vs-Stage4 |
7.569600E-01 |
| Stage3-vs-Stage4 |
4.429400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.319900E-02 |
| Normal-vs-AfricanAmerican |
4.341700E-03 |
| Normal-vs-Asian |
2.293000E-01 |
| Caucasian-vs-AfricanAmerican |
4.486100E-02 |
| Caucasian-vs-Asian |
5.273400E-01 |
| AfricanAmerican-vs-Asian |
8.747000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.774000E-02 |
| Normal-vs-Female |
3.820000E-02 |
| Male-vs-Female |
6.825400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.163430E-01 |
| Normal-vs-Age(41-60Yrs) |
7.081900E-02 |
| Normal-vs-Age(61-80Yrs) |
4.519700E-02 |
| Normal-vs-Age(81-100Yrs) |
3.391200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.105600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.148800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.936200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.391000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.275600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.195400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.413000E-01 |
| Normal-vs-Grade 2 |
4.687400E-01 |
| Normal-vs-Grade 3 |
1.668150E-02 |
| Normal-vs-Grade 4 |
4.814500E-04 |
| Grade 1-vs-Grade 2 |
4.621000E-01 |
| Grade 1-vs-Grade 3 |
1.218770E-01 |
| Grade 1-vs-Grade 4 |
1.733520E-02 |
| Grade 2-vs-Grade 3 |
1.018080E-02 |
| Grade 2-vs-Grade 4 |
1.010600E-04 |
| Grade 3-vs-Grade 4 |
6.092300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.841000E-01 |
| Normal-vs-ccB subtype |
5.160000E-04 |
| ccA subtype-vs-ccB subtype |
3.20549999877073E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.761900E-02 |
| Normal-vs-N1 |
7.058500E-02 |
| N0-vs-N1 |
4.081000E-01 |
|
|
